Aakaar Medical Technologies Ltd.
•Add ratio to table
ABOUT
KEY POINTS
Revenue Breakup Mar 2026 • Aesthetic Products: 89.0% • Aesthetic Devices & Device Consumables: 11.0%
AI Sector View
AI GENERATEDOil Gas & Consumable Fuels
Sector economics are clouded by input volatility and uneven volume trends. WPI fuel inflation is very high at 20.05% (Jul/26), crude oil output is -5.3% YoY (2026-07), natural gas is -3.7% YoY (2026-07), and natural gas consumption is -3.0% YoY (2026-06), although refinery products grew 2.7% YoY (2026-07) and coal was 7.6% YoY (2026-07). Heavy FPI outflows of INR -15293 crore over 3 months to 2026-08-31 and negative oil-linked news flow reinforce the underweight.
PROS
- Company has a good return on equity (ROE) track record: 3 Years ROE 25.6%
- Company has a healthy return on capital (ROCE) of 22.8%
- Operating margins have improved to 15.4% from 11.0%
- Attractively priced for its growth - PEG of 0.3
- Company maintains a comfortable, low leverage position
- Company comfortably covers its interest (6.1x coverage)
CONS
- Operating cash flow has been negative in recent years
- Receivables are growing faster than sales - a possible quality concern
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -1.40x)
- Free cash flow has been persistently negative
- Working capital days have increased from 130 to 287 days
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ADANIENT | 3057.10 | 55.59 | 413846.54 | 0.04 | -1461.54 | -249.67 | 32923.98 | 49.92 | 13.30 | 15.57 |
| AEGISLOG | 1353.10 | 37.96 | 47493.81 | 0.64 | 544.84 | 210.70 | 2356.86 | 37.07 | 19.76 | 30.28 |
| CPPLUS | 3830.15 | 94.94 | 45310.84 | 0.04 | 142.20 | 332.51 | 1402.42 | 89.51 | 29.48 | 14.52 |
| PREMIERENE | 974.55 | 26.57 | 44239.84 | 0.10 | 471.92 | 53.32 | 2462.59 | 35.25 | 33.72 | 29.03 |
| REDINGTON | 393.65 | 18.09 | 30774.55 | 1.52 | 453.49 | 94.65 | 34922.47 | 34.57 | 18.96 | 2.03 |
| HONASA | 470.95 | 61.70 | 15354.11 | 0.64 | 90.45 | 118.87 | 755.95 | 27.00 | 20.87 | 14.58 |
| LLOYDSENT | 69.79 | 94.88 | 10653.81 | 0.21 | 109.98 | -55.77 | 563.03 | 70.15 | 12.84 | 18.07 |
| SGMART | 751.25 | 76.16 | 9468.39 | 0.00 | 455.80 | 1310.71 | 13085.70 | 1044.08 | 10.43 | 4.49 |
| MMTC | 61.96 | 20.78 | 9294.00 | 0.00 | 104.24 | 135.52 | 0.68 | -50.00 | 33.46 | -1423.53 |
| ENTERO | 1819.35 | 63.14 | 7918.37 | 0.00 | 52.05 | 72.17 | 1940.50 | 38.23 | 10.93 | 5.00 |
| EBGNG | 683.00 | 54.67 | 7786.99 | 0.00 | 28.93 | 56.21 | 412.46 | 32.08 | 20.58 | 11.97 |
| AAKAAR | 63.00 | 13.45 | 89.29 | 0.00 | — | — | — | — | 18.45 | — |
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
No standalone quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 19 | 33 | 46 | 62 | 67 | |
| 17 | 29 | 41 | 52 | 57 | |
| Operating Profit | 2 | 4 | 5 | 10 | 10 |
| OPM % | 12.31% | 10.76% | 10.84% | 15.86% | 15.40% |
| 0 | 0 | 0 | 0 | 1 | |
| Interest | 0 | 0 | 1 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Profit before Tax | 2 | 3 | 4 | 8 | 9 |
| Tax % | 26.55% | 30.60% | 26.13% | 25.65% | 27.79% |
| Net Profit | 2 | 2 | 3 | 6 | 7 |
| EPS | 1.78 | 2.36 | 41.00 | 5.79 | 4.68 |
| Dividend Payout % | 34.60% | 24.38% | 0.00% | 0.00% | 0.00% |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 27%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 46%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -30%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 24%
- 3 Years:
- 26%
- Last Year:
- 17%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 10 | 14 |
| 7 | 9 | 12 | 13 | 40 | |
| 4 | 6 | 15 | 23 | 19 | |
| Trade Payables | 2 | 3 | 2 | 4 | 2 |
| 4 | 5 | 5 | 6 | 4 | |
| Total Liabilities | 18 | 23 | 35 | 56 | 79 |
| 0 | 0 | 0 | 0 | 0 | |
| 7 | 11 | 14 | 15 | 20 | |
| 0 | 0 | 16 | 28 | 37 | |
| Cash & Bank | 2 | 0 | 0 | 6 | 16 |
| 8 | 11 | 4 | 7 | 5 | |
| Total Assets | 18 | 23 | 35 | 56 | 79 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 1 | -2 | -8 | -5 | -8 | |
| Cash from Investing | -0 | -0 | -0 | -0 | 0 |
| Cash from Financing | -1 | 1 | 8 | 11 | 19 |
| -1 | -2 | 0 | 5 | 10 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
No announcements filed.
News
Recent coverage and analyst commentary for AAKAAR
Loading news…
AI Stock Analyst
Aakaar Medical Technologies Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account